The global psoriatic arthritis treatment market share was valued at USD 10.5 Billion in 2024. It is expected to grow to USD 23.2 Billion by 2033, exhibiting a CAGR of 8.71% during the forecast period from 2025 to 2033. Treatment options range from oral medications to biological therapies targeting immune system components with the goal of preventing disease progression, reducing pain, and...